Vanda Pharmaceuticals Inc (NAS:VNDA)
$ 5.04 -0.11 (-2.14%) Market Cap: 293.87 Mil Enterprise Value: -68.03 Mil PE Ratio: 0 PB Ratio: 0.54 GF Score: 81/100

Q3 2019 Vanda Pharmaceuticals Inc Earnings Call Transcript

Nov 06, 2019 / 09:30PM GMT
Release Date Price: $13.14 (-2.67%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Third Quarter 2019 Vanda Pharmaceuticals Earnings Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded.

(Operator Instructions) I would now like to hand the conference over to your speaker today, Mr. Jim Kelly, Executive Vice President and Chief Financial Officer. Please go ahead, sir.

James Patrick Kelly
Vanda Pharmaceuticals Inc. - Executive VP, CFO & Treasurer

All right. Thank you very much. Good afternoon, and thank you for joining us to discuss Vanda Pharmaceuticals' third quarter 2019 performance. Our third quarter 2019 results were released this afternoon and are available on the SEC's EDGAR System and on our website, www.vandapharma.com. In addition, we are providing live and archived versions of this conference call on our website.

Joining me today on the call is Dr. Mihales Polymeropoulos, our President and CEO. Following my introductory remarks,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot